Another Product Liability Lawsuit Filed Over Trasylol Injuries
People who took the drug Trasylol to control bleeding during heart surgeries have sued the drug’s maker for kidney damage and increased risks of other serious injuries they claim were caused by the drug, which has since been recalled.
Continue →Trasylol Lawsuits Filed in Illinois Circuit Court
Patients who say use of the drug Trasylol to control bleeding during heart bypass surgery caused them or their loved ones to suffer injuries or die have sued the drug’s maker for failing to warn of kidney damage, organ failure, and other potentially deadly side effects.
Continue →Bayer Failed to Warn of Trasylol Side Effects, New Lawsuit Claims
Bayer Pharmaceuticals ignored numerous studies showing its blood-clotting drug Trasylol could be dangerous and failed to warn patients of potentially fatal side effects, according to a new lawsuit.
Continue →Trasylol: Blood-Clotting Drug Tied to Kidney Damage, Heart Attack, and Stroke
Trasylol, the drug designed to reduce bleeding during heart bypass surgery, was recalled in 2007 after medical researchers found the drug increased the risk of kidney damage, heart attack, stroke, and death more than similar drugs. First approved by the Food and Drug Administration in 1993, Trasylol helped prevent life-threatening bleeding during cardiac and bypass surgeries by helping the blood clot faster, thus reducing the need for blood transfusions.
Continue →
facebook
rss
twitter